These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20659107)

  • 1. Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.
    Farkas AS; Rudas L; Makra P; Csík N; Leprán I; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2010 Dec; 161(7):1477-95. PubMed ID: 20659107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits.
    Vincze D; Farkas AS; Rudas L; Makra P; Csík N; Leprán I; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2008 Jan; 153(1):75-89. PubMed ID: 17965737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
    Orosz S; Sarusi A; Csík N; Papp JG; Varró A; Farkas S; Forster T; Farkas AS; Farkas A
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):266-76. PubMed ID: 24887684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.
    Farkas AS; Makra P; Csík N; Orosz S; Shattock MJ; Fülöp F; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2009 Mar; 156(6):920-32. PubMed ID: 19222480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
    Dhein S; Perlitz F; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):631-44. PubMed ID: 18648775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
    Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
    Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations.
    Champeroux P; Thireau J; Judé S; Laigot-Barbé C; Maurin A; Sola ML; Fowler JS; Richard S; Le Guennec JY
    Br J Pharmacol; 2015 Jun; 172(11):2878-91. PubMed ID: 25625756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.
    Nalos L; Varkevisser R; Jonsson MK; Houtman MJ; Beekman JD; van der Nagel R; Thomsen MB; Duker G; Sartipy P; de Boer TP; Peschar M; Rook MB; van Veen TA; van der Heyden MA; Vos MA
    Br J Pharmacol; 2012 Jan; 165(2):467-78. PubMed ID: 21718297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
    Bossu A; Houtman MJC; Meijborg VMF; Varkevisser R; Beekman HDM; Dunnink A; de Bakker JMT; Mollova N; Rajamani S; Belardinelli L; van der Heyden MAG; Vos MA
    Br J Pharmacol; 2018 Jun; 175(12):2470-2482. PubMed ID: 29582428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
    Cheng HC; Incardona J
    J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model.
    Farkas A; Dempster J; Coker SJ
    Br J Pharmacol; 2008 Jul; 154(5):958-70. PubMed ID: 18587444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
    Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
    Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.